Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alector Inc (ALEC)

Alector Inc (ALEC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 582,154
  • Shares Outstanding, K 95,749
  • Annual Sales, $ 97,060 K
  • Annual Income, $ -130,390 K
  • 60-Month Beta 0.81
  • Price/Sales 5.88
  • Price/Cash Flow N/A
  • Price/Book 4.23
Trade ALEC with:

Options Overview Details

View History
  • Implied Volatility 120.16% ( +20.73%)
  • Historical Volatility 55.34%
  • IV Percentile 97%
  • IV Rank 52.44%
  • IV High 212.72% on 11/13/23
  • IV Low 18.09% on 04/17/23
  • Put/Call Vol Ratio 0.05
  • Today's Volume 21
  • Volume Avg (30-Day) 74
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 1,902
  • Open Int (30-Day) 1,279

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.46
  • Number of Estimates 6
  • High Estimate -0.34
  • Low Estimate -0.56
  • Prior Year -0.55
  • Growth Rate Est. (year over year) +16.36%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.82 +3.44%
on 03/18/24
7.57 -20.48%
on 03/01/24
-0.97 (-13.88%)
since 02/28/24
3-Month
5.49 +9.65%
on 01/19/24
8.90 -32.36%
on 01/09/24
-1.98 (-24.75%)
since 12/28/23
52-Week
3.66 +64.48%
on 11/16/23
9.06 -33.59%
on 08/04/23
-0.21 (-3.37%)
since 03/28/23

Most Recent Stories

More News
Alector: Q4 Earnings Snapshot

Alector: Q4 Earnings Snapshot

ALEC : 6.02 (-0.99%)
Alector Prices New Public Offering

Alector, Inc. (NASDAQ: ALEC) shares fell back Wednesday. The San Francisco-based biotechnology company, ...

ALEC : 6.02 (-0.99%)
Alector: Q3 Earnings Snapshot

Alector: Q3 Earnings Snapshot

ALEC : 6.02 (-0.99%)
Alector: Q2 Earnings Snapshot

Alector: Q2 Earnings Snapshot

ALEC : 6.02 (-0.99%)
Does Alector (ALEC) Have the Potential to Rally 86.38% as Wall Street Analysts Expect?

The consensus price target hints at an 86.4% upside potential for Alector (ALEC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate...

ALEC : 6.02 (-0.99%)
Alector (ALEC) Reports Q1 Loss, Tops Revenue Estimates

Alector (ALEC) delivered earnings and revenue surprises of 26.67% and 79.32%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ALEC : 6.02 (-0.99%)
CLSD : 1.5300 (-8.38%)
Alector: Q1 Earnings Snapshot

Alector: Q1 Earnings Snapshot

ALEC : 6.02 (-0.99%)
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?

Acadia (ACAD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ACAD : 18.49 (+1.59%)
ALEC : 6.02 (-0.99%)
Are Options Traders Betting on a Big Move in Alector (ALEC) Stock?

Investors need to pay close attention to Alector (ALEC) stock based on the movements in the options market lately.

ALEC : 6.02 (-0.99%)
Repare Therapeutics Inc. (RPTX) Reports Q4 Loss, Tops Revenue Estimates

Repare Therapeutics Inc. (RPTX) delivered earnings and revenue surprises of -2.74% and 84.75%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

RPTX : 4.71 (+0.86%)
ALEC : 6.02 (-0.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Alector Inc. is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Its product portfolio includes AL001, AL101, Al002 and AL003 which are in clinical stage. Alector Inc. is headquartered in South San Francisco,...

See More

Key Turning Points

3rd Resistance Point 6.38
2nd Resistance Point 6.28
1st Resistance Point 6.15
Last Price 6.02
1st Support Level 5.92
2nd Support Level 5.82
3rd Support Level 5.69

See More

52-Week High 9.06
Fibonacci 61.8% 7.00
Fibonacci 50% 6.36
Last Price 6.02
Fibonacci 38.2% 5.72
52-Week Low 3.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar